全文获取类型
收费全文 | 975篇 |
免费 | 44篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 46篇 |
妇产科学 | 11篇 |
基础医学 | 164篇 |
口腔科学 | 20篇 |
临床医学 | 69篇 |
内科学 | 186篇 |
皮肤病学 | 30篇 |
神经病学 | 28篇 |
特种医学 | 185篇 |
外国民族医学 | 5篇 |
外科学 | 122篇 |
综合类 | 40篇 |
预防医学 | 42篇 |
眼科学 | 16篇 |
药学 | 35篇 |
中国医学 | 1篇 |
肿瘤学 | 26篇 |
出版年
2022年 | 5篇 |
2021年 | 17篇 |
2020年 | 4篇 |
2019年 | 17篇 |
2018年 | 25篇 |
2017年 | 11篇 |
2016年 | 17篇 |
2015年 | 23篇 |
2014年 | 11篇 |
2013年 | 36篇 |
2012年 | 26篇 |
2011年 | 36篇 |
2010年 | 25篇 |
2009年 | 25篇 |
2008年 | 35篇 |
2007年 | 33篇 |
2006年 | 33篇 |
2005年 | 28篇 |
2004年 | 25篇 |
2003年 | 20篇 |
2002年 | 28篇 |
2001年 | 22篇 |
2000年 | 21篇 |
1999年 | 12篇 |
1998年 | 23篇 |
1997年 | 44篇 |
1996年 | 35篇 |
1995年 | 38篇 |
1994年 | 22篇 |
1993年 | 25篇 |
1992年 | 11篇 |
1991年 | 14篇 |
1990年 | 17篇 |
1989年 | 24篇 |
1988年 | 22篇 |
1987年 | 31篇 |
1986年 | 33篇 |
1985年 | 23篇 |
1984年 | 18篇 |
1983年 | 10篇 |
1982年 | 14篇 |
1981年 | 16篇 |
1980年 | 13篇 |
1979年 | 3篇 |
1978年 | 10篇 |
1977年 | 8篇 |
1976年 | 8篇 |
1975年 | 8篇 |
1974年 | 6篇 |
1973年 | 3篇 |
排序方式: 共有1028条查询结果,搜索用时 15 毫秒
1.
Study DesignSystematic review.IntroductionContrast baths are used as an intervention in hand therapy, yet it is unclear which patients, if any, benefit from this intervention.Purpose of the StudyTo examine the nature and quality of the evidence regarding the use of contrast baths using a systematic review process.MethodsOf a total of 28 clinical research articles on contrast baths, from 1938 forward, ten met the inclusion criteria set by the authors.ResultsThese studies addressed the physiological changes of hot and cold on blood flow, intramuscular temperature, subcutaneous temperature, and the influence of room temperature and age. The subjects included normal/healthy volunteers and patients with a diagnosis of rheumatoid arthritis, diabetes, or foot/ankle injuries. The diversity of conditions, protocols, and outcomes limited the ability to make definitive conclusions on efficacy.ConclusionsThe contrast bath procedure may increase superficial blood flow and skin temperature, though the evidence on the impact on edema is conflicting. No relationship between physiologic effects and functional outcomes has been established.Level of Evidence: 2A 相似文献
2.
3.
4.
5.
C. M. Lazaro W. Y. Guo M. Sami T. Hindmarsh K. Ericson A. L. Hulting J. Wersäll 《Neuroradiology》1994,36(2):111-114
In a group of 69 patients with pituitary tumours, 12 were found to have evidence of intratumoral haemorrhage on MRI, characterized by high signal intensity on short TR/TE sequences. This was verified in all but 1 patient. The majority of the bleedings occurred in macroadenomas. Five (42%) were prolactinomas and 4 (33%) were non-functioning adenomas. There were 2 GH- and 1 ACTH-secreting tumours. All 5 patients with prolactinomas were on bromocriptine medication. Two of the patients had a clinical picture of pituitary apoplexy. The haemorrhage was not large enough to prompt surgery in any of the patients. However, surgical verification of the diagnosis was obtained in 5 cases, while 6 patients were examined with follow-up MRI. 相似文献
6.
7.
P. Mrel K. Hoang-Xuan M. Sanson A. Moreau-Aubry E. K. Bijlsma C. Lazaro J. P. Moisan F. Resche I. Nishisho X. Estivill J. Y. Delattre M. Poisson C. Theillet T. Hulsebos O. Delattre G. Thomas 《Genes, chromosomes & cancer》1995,13(3):211-216
The NF2 gene is a putative tumor-suppressor gene that, when it is altered in the germline, causes neurofibromatosis type 2, a tumor-susceptibility disease that mainly predisposes to schwannomas and meningiomas. The recent isolation of the NF2 gene on chromosome 22 allows the identification of somatic mutations in human tumors. We have searched for mutations of the NF2 gene in 331 primary human tumors using a screening method based on denaturing gradient gel electrophoresis, which allows the detection of mutations in 95% of the coding sequence. Mutations were observed in 17 of 57 meningiomas and in 30 of 89 schwannomas. No mutations were observed for 17 ependymomas, 70 gliomas, 23 primary melanomas, 24 pheochromocytomas, 15 neuroblastomas, 6 medulloblastomas, 15 colon cancers, and 15 breast cancers. All meningiomas and one-half of the schwannomas with identified NF2 mutations demonstrated chromosome 22 allelic losses. We conclude that the involvement of the NF2 gene in human tumorigenesis may be restricted to schwannomas and meningiomas, where it is frequently inactivated by a two-hit process. © 1995 Wiley-Liss, Inc. 相似文献
8.
In recent reports we described novel hybridization patterns (HP) corresponding to 22 potentially new HLA-B locus alleles in a panel of 547 subjects studied by PCR-SSOP. Three of them correspond to new subtypes of B35. To confirm the hybridization results we have isolated DNA from PBL and performed PCR, DNA cloning and nucleotide sequencing. One of the alleles, locally called B-3505v was found in three individuals: two Hispanic, one Caucasoid. It differs from B*3505 by 3 nucleotide substitutions that lead to changes in residues 94 (Ile > Thr), 95 (Ile > Leu) and 103 (Val > Leu). B-3505v differs from B*3501 in residues 97 and 103. Another allele called B-3508v, was found in 7 individuals, (6 of 122 Toba Indians, 1 of 18 Pilaga Indians). It differs from B*3509 in two silent nucleotide substitutions (codons 135 and 138) and in one substitution in residue 156 (Arg > Leu). The new allele has a hybrid sequence between B* 3508 and B*4801. A third subtype, locally called B-3504v, observed in two Hispanic individuals, is identical to B*3512. B*3512 differs from B*3504 by 3 nucleotides and one amino acid. Substitutions in residue 95 contribute to the structure of specificity pocket F, 97 to C and E, and 156 to pockets D and E. Therefore it is possible that some of the new alleles may have different peptide binding profiles. Since differences in residue 156 have been shown to affect allorecognition and mediate GvHD, identification of such variants may have important implications in transplantation and perhaps in studies of immune responses to peptides and pathogens. 相似文献
9.
Cholecystokinin-decreased food intake in rhesus monkeys 总被引:1,自引:0,他引:1
10.
This study analyses the influence of female and male patient age and human
menopausal gonadotrophin (HMG) requirements on clinical pregnancy rates and
live birth rates with ovulation stimulation using HMG in combination with
intrauterine insemination (IUI). In this study, 363 consecutive HMG/IUI
treatment cycles in 184 patients carried out at a university fertility
centre were analysed in a retrospective fashion. The main outcomes measured
were clinical pregnancy rates and live birth rates. Increased female
partner age (> or = 35) and male partner age (> or = 40) were found
to negatively influence pregnancy rates with HMG/ IUI therapy. In addition,
this study demonstrated a critical threshold of HMG requirements beyond
which pregnancy did not occur. No pregnancies occurred in treatment cycles
requiring > 25 ampoules (1875 IU) of menotrophins to achieve follicular
maturity, irrespective of patient age. In conclusion, female partner age,
male partner age, and HMG requirements all significantly influence
pregnancy rates with HMG/IUI therapy.
相似文献